Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)
PHP
1 other identifier
observational
15
1 country
1
Brief Summary
Study come to investigate the correlation between visual fields (VF) defects map generated by preferential hyperacuity perimeter (PHP) and features of the choroidal neovascular lesions (CNV) demonstrated by Optical Coherence Tomography(OCT). To investigate the Foresee PHP ability to asses treatment progression post treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2008
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2009
CompletedJanuary 28, 2009
January 1, 2009
6 months
May 26, 2008
January 27, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To investigate the correlation between visual fields (VF) defects map generated by preferential hyperacuity perimeter (PHP) and features of the choroidal neovascular lesions (CNV) demonstrated by Optical Coherence Tomography(OCT).
6 month
Secondary Outcomes (1)
To investigate the Foresee PHP ability to asses treatment progression post treatment.
6 month
Study Arms (1)
1
Subjects diagnosed as new CNV or treated CNV
Interventions
computerized test
Eligibility Criteria
* Subjects diagnosed as new CNV or treated CNV * Age \>50 years * VA with habitual correction \<20/160 in the study eye
You may qualify if:
- Capable and willing to sign a consent form and participate in the study
- Subjects diagnosed as new CNV or treated CNV
- Age \>50 years
- VA with habitual correction \<20/160 in the study eye
- Ability to understand instructions
You may not qualify if:
- Evidence of macular disease other than AMD or glaucoma in the study eye
- Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy,
- Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
- Patients diagnosed with geographic atrophy (GA)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sorasky Medical center
Tel Aviv, Israel
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anat Loewenstein, Prof.
Sorasky Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 26, 2008
First Posted
June 6, 2008
Study Start
June 1, 2008
Primary Completion
December 1, 2008
Study Completion
January 1, 2009
Last Updated
January 28, 2009
Record last verified: 2009-01